# Medical Isotope Production Without Highly Enriched Uranium(2009)

## Chapter: Appendix F: Present Value Calculation

« Previous: Appendix E: Correspondence with Atomic Energy of Canada Limited
Page 194
Suggested Citation:"Appendix F: Present Value Calculation." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
×
Page 195
Suggested Citation:"Appendix F: Present Value Calculation." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
×

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix F Present Value Calculation I n simple terms, a dollar received in the future is worth less than a dollar received today. One reason for this is inflationâa general increase in the prices of all goods and services. Suppose we assume, however, that there is no inflation or, equivalently that amounts measured in nominal (sometimes called current) dollars are converted into amounts measured in real (sometimes called constant) dollars. Individuals would still prefer a real (inflation-adjusted) dollar today to a real dollar in the future. There are two main reasons. First, todayâs dollar could be invested and would yield a positive real return, thereby providing the opportunity to buy more goods in the future. Second, all things being equal, individuals would rather consume now than in the future. This means that the value of a dol- lar received in the future is discounted relative to a dollar received now. Mathematically, the present value, PV, of \$1 received in one year is 1 PV = 1+ i where i is the appropriate real discount rate; it might, for example, reflect a companyâs real return on investment or an individualâs real saving rate. The present value of \$1 received in n yearsâ time is 1 PV = (1 + i )n 194

APPENDIX F 195 This term is called the present value factor or the discount factor. It equals the present value of \$1 received in n years when the discount rate is i, compounded annually. For example, if a company receives \$1 in 30 years time, and it uses a discount rate of 7 percent, then the present value factor is 1/(1 + .07)30 = 0.13. In other words, \$1 in 30 yearsâ time is equivalent to 13 cents today. As amounts are received further in the future, n increases and the present value of that amount decreases. Table 10.1 supposes that firms receive an incremental increase in rev- enues each year over a fixed number of years, 55 or 30. Such payment streams are called an annuity. The present value of an annuity of \$1 Â­ eceived each year for 30 years, denoted ain , equals r 1 1 1 ain = + + + (1 + i ) (1 + i ) 1 2 (1 + i )n This can be shown to equal 1 â (1 + i ) ân ain = i Thus, for example, the present value of an annuity of \$1 per year received for 30 years at a discount rate of 7 percent would equal \$12.41. Consequently, the present value of \$7.02 million per year for 30 years at a discount rate of 7 percent would equal \$7.02 Ã 12.41 million = \$87.1 million. This amount is rounded down to \$85 million in Table 10.1. â \$225 Ã 312,000 Ã 0.10 = \$7.02 million.

Next: Appendix G: Glossary »
Medical Isotope Production Without Highly Enriched Uranium Get This Book
×

This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel.

The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply.

1. ×

## Welcome to OpenBook!

You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

Do you want to take a quick tour of the OpenBook's features?

No Thanks Take a Tour »
2. ×

« Back Next »
3. ×

...or use these buttons to go back to the previous chapter or skip to the next one.

« Back Next »
4. ×

Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

« Back Next »
5. ×

To search the entire text of this book, type in your search term here and press Enter.

« Back Next »
6. ×

Share a link to this book page on your preferred social network or via email.

« Back Next »
7. ×

View our suggested citation for this chapter.

« Back Next »
8. ×